California Public Employees Retirement System Coherus Bio Sciences, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$12.95 - $15.41 $1.52 Million - $1.81 Million	-117,700 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$14.42 - $21.39 $157,610 - $233,792	-10,930 Reduced 8.5%	117,700 $1.72 Million
Q4 2020 Feb 02, 2021	SELL	$16.56 - $18.94 $41,400 - $47,350	-2,500 Reduced 1.91%	128,630 $2.24 Million
Q3 2020 Nov 05, 2020	BUY	$17.41 - $19.89 $52,230 - $59,670	3,000 Added 2.34%	131,130 $2.41 Million
Q2 2020 Aug 12, 2020	SELL	$14.43 - $19.16 $163,838 - $217,542	-11,354 Reduced 8.14%	128,130 $2.29 Million
Q1 2020 May 12, 2020	SELL	$11.67 - $22.53 $775,168 - $1.5 Million	-66,424 Reduced 32.26%	139,484 $2.26 Million
Q4 2019 Jan 27, 2020	BUY	$16.33 - $21.37 $1.49 Million - $1.95 Million	91,258 Added 79.6%	205,908 $3.71 Million
Q3 2019 Oct 31, 2019	BUY	$16.3 - $23.37 $1.57 Million - $2.24 Million	96,014 Added 515.21%	114,650 $2.32 Million
Q2 2019 Aug 15, 2019	BUY	$13.1 - $22.1 $98,250 - $165,750	7,500 Added 67.35%	18,636 $412,000
Q1 2019 May 03, 2019	BUY	$8.38 - $15.5 $93,319 - $172,608	11,136 New	11,136 $152,000

Others Institutions Holding CHRS

# of Institutions

132

Shares Held

76.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$13.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$13.3 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$12.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$3.58 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$3.37 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account